While previous studies have noted that hypogonadism (HG) may pose a significant economic and quality-of-life burden, no studies have evaluated the impact of HG on healthcare utilization and costs in the United States.
Publication
The journal of sexual medicine, 2012, Vol 9, Issue 9, p2438